Status:
RECRUITING
Family Study of Lymphoproliferative Disorders
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell
Eligibility:
All Genders
18-100 years
Brief Summary
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolle...
Eligibility Criteria
Inclusion
- At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00626496
Start Date
April 1 2004
End Date
December 31 2029
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905